| 24081/34347 | US=8 / Câncer Melo M. Estimuladores da população granulocítica. In: ___. Leucemias & linfomas altas do sangue periférico. São Paulo: Livraria Médica Paulista, 2008. p. 145-8. ISBN 85-99305-23-2. ESTIMULADORES DA POPULACAO GRANULOCITICA; TIMOMODULINA; FILGRASTIMA |
| 24082/34347 | US=8 / Câncer Melo M. Destaques e curiosidades. In: ___. Leucemias & linfomas altas do sangue periférico. São Paulo: Livraria Médica Paulista, 2008. p. 149-63. ISBN 85-99305-23-2. |
| 24083/34347 | US=8 / Tórax Lennon AM, Penman ID. Endoscopic ultrasound in esophageal cancer. In: Rankin SC. Carcinoma of the esophagus. New York: Cambridge University Press, 2008. p. 44-61. (Contemporary issues in cancer imaging) ISBN 978-0-521-88285-9. |
| 24084/34347 | US=80 / Biol/Mol Willard B, Kaveti S, Kinter MT. Proteomics technologies: current and emergig mass spectrometry instrumentation and methods for proteomic analyses. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 3-35. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. ESPECTROMETRIA DE MASSA; ION FRAGMENTACAO; PROTEOMICA; ANALISE DE MASSA |
| 24085/34347 | US=80 / Biol/Mol Lee K, Wang T, Rehman A, Wang Y, Daoud SS. Cell signaling proteomics: integration of genomics and proteomics in dissecting p53 signaling. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 39-57. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. FARMACOGENOMICA; PROTEOMICA; P53; S100A4; RB18A; CANCER DO COLON |
| 24086/34347 | US=65 / Biol/Mol Bugge TH. Physiological functions of plasminogen activation: effects of gene deficiencies in humans and mice. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 183-201. ISBN 978-0-387-69056-8. SISTEMA DE ATIVACAO DO PLASMINOGENIO; FUNCOES FISIOLOGICAS; DEFICIENCIAS GENETICAS; HUMANOS; RATOS; ALFA2-ANTIPLASMINA; PAI-1 |
| 24087/34347 | US=80 / Biol/Mol Alaoui-Jamali MA, Pinto D. Proteomic profiling of tyrosine kinases as pharmacological endpoints for targeted cancer therapy. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 59-77. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. TIROSINA-QUINASES PROTEICAS; CANCER; TERAPIA-ALVO; PROTEOMICA |
| 24088/34347 | US=80 / Biol/Mol Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA |
| 24089/34347 | US=80 / Biol/Mol Annunziata CM, Roque DM, Azad N, Kohn EC. Application of serum and tissue proteomics to understand and detect solid tumors. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 101-20. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. PROTEOMICA; ENSAIO CLINICO; TUMOR SOLIDO; ESPECTROMETRIA DE MASSA; TISSUE MICROARRAY |
| 24090/34347 | US=80 / Biol/Mol Sarto C, Proserpio V, Magni F, Mocarelli P. Insight on renal cell carcinoma proteome. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 121-37. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. CARCINOMA DE CELULAS RENAIS PROTEOMA; CARCINOMA DE CELULAS RENAIS; PROTEOMA; GENOMICA; BIOMARCADORES; ELECTROFORESE BIDIMENSIONAL; ANALISE SEROLOGICA PROTEOMA; MODIFICACAO POS-TRADUCAO |
| 24091/34347 | US=80 / Biol/Mol Reumond MA, Beshay M, Lippert H. Proteomics in lung cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 139-59. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. PROTEOMICA NO CANCER DE PULMAO; CANCER DE PULMAO; PROTEOMICA; HNRNP; CITOQUERATINAS; LCM |
| 24092/34347 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 24093/34347 | US=80 / Biol/Mol Brünner N, Holten-Andersen M, Sweep F, Foekens J, Schmitt M, Duffy MJ. New tumor biomarkers. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 189-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. BIOMARCADORES TUMORAIS; PRE-ANALITICA VARIAVEIS; VARIAVEL ANALITICA; POS-ANALITICA VARIAVEL; MARCADORES DE DETECCAO DE MARCADORES DE TRIAGEM; MARCADORES PROGNOSTICOS; MARCADORES PREDITIVOS; MARCADORES DE MONITORAMENTO |
| 24094/34347 | US=80 / Biol/Mol Apweiler R, Mueller M. Bioinformatics and regulatory aspects of proteomics: annotating the human proteome. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 211-35. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. HUMANO; PROTEOMICA; ANOTACAO FUNCIONAL; INTEGRACAO DE DADOS; PADRONIZACAO DE DADOS |
| 24095/34347 | US=80 / Biol/Mol Li D, Hackett J, Chan M, Pennello G, Gutman S. Regulatory issues in the co-development of oncology drugs and proteomic tests: an overview. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 237-58. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. |
| 24096/34347 | US=84 / Biol/Mol Jakowlew SB. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B ligands, TGF-B receptors, and smads. In: ___. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 3-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B LIGANTES; TGF-B RECEPTORES; SMAD; TRANSDUCAO DE SINAL; PROLIFERACAO |
| 24097/34347 | US=84 / Biol/Mol Seoane J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B signaling in homeostasis and cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 23-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24098/34347 | US=84 / Biol/Mol Todorovic V, Rifkin DB. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B availability: latent TGF-B and latent TGF-B binding proteins. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 37-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; LATENCIA PROTEINA ASSOCIADA; LATENCIA ASSOCIADA PROTEINA LATENTE; PROTEINA TGF-B DE LIGACAO; MATRIZ EXTRACELULAR; PLASMINA; THROBOSPODIN-1 |
| 24099/34347 | US=84 / Biol/Mol Hyytiäinen M, Koli K, Keski-Oja J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: biological functions of latent TGF-B-binding and activation of TGF-B. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 57-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24100/34347 | US=84 / Biol/Mol Atfi A, Bourgeade MF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulators of smad2/3 transcription and phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 77-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FOSFORILACAO SMAD; TRANSLOCACAO NUCLEAR DE SMADS; ATIVIDADE TRANSCRICIONAL SMAD; COATIVADORES SMADS; SMADS COREPRESSORS |